Clinical Trial Update: SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating SGLT2 inhibitors as first-line therapy to prevent renal decline in adults with Type 2 diabetes; the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: The George Institute | Conditions: Type 2 Diabetes | Phase 3 | Status: RECRUITING